Swissmedic specifies Requirements for GMP Certificates
Recommendation

4/5 March 2026
Bern, Switzerland
Role, Accountability and Liability of the Responsible Person
For companies with a valid establishment licence for the manufacture of medicinal products and transplant products, Swissmedic issues GMP Certificates on request. GMP Certificates from Swissmedic show the date of the inspection on which the certificate is based. They do not contain an expiry date. However, in accordance with the practice for GMP Certificates in the EU database EudraGMDP, it is often assumed by the companies or by other authorities that GMP Gertificates based on an inspection which took place more than three years ago are no longer meaningful in terms of compliance status and therefore lose their validity.
Swissmedic GMP Gertificates
Although the coronavirus crisis created a complicated situation for inspections, the planned routine inspections in Switzerland were carried out, and the usual inspection intervals were maintained. Consequently, there is no longer any need to generally extend the validity dates on Swissmedic GMP Certificates.
Information about the currently valid establishment licence and the date of the last inspection is available on the Swissmedic website for all companies that have an establishment licence in accordance with the new legislation.
Swissmedic refers to licences issued under the new legislation.
GMP Certificates issued by the EMA (European Medicine Agency)
The EMA has granted an automatic, across-the-board extension for GMP Certificates issued in the EudraGMDP Database until the end of 2022. This is accepted by Swissmedic.
Source: Swissmedic latest news
Related GMP News
20.01.2026New Ph. Eur. Publication Schedule
19.01.2026EU Pharma Package: EMA with single Point of Information
14.01.2026European QP Association Developments September through December 2025
14.01.2026Could a change of ownership be relevant to GMP?
07.01.2026Is QP Certification required when Products do not enter EU Territory?
17.12.2025EU Reaches Landmark on Reform of Pharmaceutical Legislation

